4,764
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Biological activity of terpene compounds produced by biotechnological methods

, , , , , & show all
Pages 1096-1107 | Received 04 Sep 2014, Accepted 30 Sep 2015, Published online: 25 Jan 2016

Figures & data

Figure 1. A GC-FID chromatogram and structures of main metabolites recovered after biotransformation of (R)-(+)-limonene by M. minutissima; IS, internal standard (A). Main products and a GC-FID chromatogram of the post-reaction mixture after (−)-α-pinene biotransformation by C. pannorum. IS, internal standard (B).

Figure 1. A GC-FID chromatogram and structures of main metabolites recovered after biotransformation of (R)-(+)-limonene by M. minutissima; IS, internal standard (A). Main products and a GC-FID chromatogram of the post-reaction mixture after (−)-α-pinene biotransformation by C. pannorum. IS, internal standard (B).

Figure 2. The effect of 24 h treatment of HT29 (A and C) and CCD 841 CoTr (B and D) cells with (R)-(+)-limonene and its derivatives. MTT assay (A and B) and Neutral Red assay (NR) (C and D). The results are presented as a percentage of the controls, arbitrarily set to 100%. The figure shows an average of three independent experiments.

Figure 2. The effect of 24 h treatment of HT29 (A and C) and CCD 841 CoTr (B and D) cells with (R)-(+)-limonene and its derivatives. MTT assay (A and B) and Neutral Red assay (NR) (C and D). The results are presented as a percentage of the controls, arbitrarily set to 100%. The figure shows an average of three independent experiments.

Figure 3. The effect of 24 h treatment of HT29 (A and C) and CCD 841 CoTr (B and D) cells with (−)-α-pinene and its derivatives. MTT assay (A and B) and Neutral Red assay (NR) (C and D). The results are presented as a percentage of the controls, arbitrarily set to 100%. The figure shows an average of three independent experiments.

Figure 3. The effect of 24 h treatment of HT29 (A and C) and CCD 841 CoTr (B and D) cells with (−)-α-pinene and its derivatives. MTT assay (A and B) and Neutral Red assay (NR) (C and D). The results are presented as a percentage of the controls, arbitrarily set to 100%. The figure shows an average of three independent experiments.

Figure 4. IL-6 secretion in culture of CCD 841 CoTr cells during 24 h incubation with (R)-(+)-limonene or (−)-α-pinene and their derivatives. ELISA test. *p ≤0.01 – a culture treated with terpenes compared with a non-treated control culture. #p ≤0.01 – a culture treated with terpenes compared with a non-treated control culture after pre-incubation with LPS.

Figure 4. IL-6 secretion in culture of CCD 841 CoTr cells during 24 h incubation with (R)-(+)-limonene or (−)-α-pinene and their derivatives. ELISA test. *p ≤0.01 – a culture treated with terpenes compared with a non-treated control culture. #p ≤0.01 – a culture treated with terpenes compared with a non-treated control culture after pre-incubation with LPS.

Table 1. Nitric oxide production by human colon tumor cell (HT29) and normal colonic epithelial cell (CCD 841 CoTr) after 24 h incubation with (R)-(+)-limonene and its derivatives.

Table 2. Nitric oxide production by human colon tumour cell (HT29) and normal colonic epithelial cell (CCD 841 CoTr) after 24 h incubation with (−)-α-pinene and its derivatives.

Table 3. IC50 values obtained after human colon tumour cell (HT29) and human normal colonic epithelial cell (CCD 841 CoTr) after 24 h incubation with (R)-(+)-limonene and (−)-α-pinene and their derivatives (MTT and Neutral Red analysis).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.